Dedicated to evidence-based medicine and the evaluation of new therapeutic approaches in the field.
作者信息
Schindler Christoph
出版信息
Ther Adv Endocrinol Metab. 2011 Aug;2(4):151-3. doi: 10.1177/2042018811417971.
Abstract
摘要
相似文献
1
Dedicated to evidence-based medicine and the evaluation of new therapeutic approaches in the field.
Ther Adv Endocrinol Metab. 2011 Aug;2(4):151-3. doi: 10.1177/2042018811417971.
2
Personalized Cardiovascular Regenerative Medicine: Targeting the Extreme Stages of Life.
Front Cardiovasc Med. 2019 Nov 27;6:177. doi: 10.3389/fcvm.2019.00177. eCollection 2019.
3
Rheumatoid arthritis of the hand and wrist: comparison of three imaging techniques.
AJR Am J Roentgenol. 2004 Apr;182(4):937-43. doi: 10.2214/ajr.182.4.1820937.
4
Evidence-based medicine in otolaryngology, part 1: the multiple faces of evidence-based medicine.
Otolaryngol Head Neck Surg. 2010 May;142(5):637-46. doi: 10.1016/j.otohns.2010.01.018.
5
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Is the scientific publishing of complementary and alternative medicine objective?
J Altern Complement Med. 1999 Dec;5(6):587-94. doi: 10.1089/acm.1999.5.587.
7
[Influence of acute stroke care organization on the implementation of clinical practice guidelines].
Rev Neurol (Paris). 2009 Nov;165(11):949-56. doi: 10.1016/j.neurol.2009.02.007. Epub 2009 Apr 7.
8
Trend analysis of disaster health articles in peer-reviewed publications pre- and post-9/11.
Am J Disaster Med. 2008 Nov-Dec;3(6):369-76.
9
Evaluation of medial meniscus tears and meniscal stability: weight-bearing MRI vs arthroscopy.
Eur J Radiol. 2013 Apr;82(4):633-9. doi: 10.1016/j.ejrad.2012.10.018. Epub 2012 Nov 28.
10
Impact of a Dedicated Teaching Attending Experience on a Required Emergency Medicine Clerkship.
West J Emerg Med. 2019 Dec 18;21(1):58-64. doi: 10.5811/westjem.2019.11.44399.
引用本文的文献
1
The Curcumin Analogs 2-Pyridyl Cyclohexanone Induce Apoptosis via Inhibition of the JAK2-STAT3 Pathway in Human Esophageal Squamous Cell Carcinoma Cells.
Front Pharmacol. 2018 Aug 21;9:820. doi: 10.3389/fphar.2018.00820. eCollection 2018.
本文引用的文献
1
[Pharmacological concepts for the treatment of obesity - a therapeutic meander?].
Dtsch Med Wochenschr. 2011 Aug;136(31-32):1570-3. doi: 10.1055/s-0031-1281554. Epub 2011 Aug 1.
2
Bardoxolone methyl and kidney function in CKD with type 2 diabetes.
N Engl J Med. 2011 Jul 28;365(4):327-36. doi: 10.1056/NEJMoa1105351. Epub 2011 Jun 24.
3
Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes.
Endocr Rev. 2011 Aug;32(4):515-31. doi: 10.1210/er.2010-0029. Epub 2011 May 23.
4
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.
Diabetes Care. 2011 Apr;34(4):916-22. doi: 10.2337/dc10-1068.
5
Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9.
J Lipid Res. 2011 Apr;52(4):679-87. doi: 10.1194/jlr.M013664. Epub 2011 Jan 24.
6
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial.
Lancet. 2010 Aug 14;376(9740):517-23. doi: 10.1016/S0140-6736(10)60935-X.
7
Withdrawal of sibutramine leaves European doctors with just one obesity drug.
BMJ. 2010 Jan 25;340:c477. doi: 10.1136/bmj.c477.
8
ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.
Ther Adv Cardiovasc Dis. 2008 Aug;2(4):233-48. doi: 10.1177/1753944708094309.
9
Interleukin-1-receptor antagonist in type 2 diabetes mellitus.
N Engl J Med. 2007 Apr 12;356(15):1517-26. doi: 10.1056/NEJMoa065213.
10
Inflammation and metabolic disorders.
Nature. 2006 Dec 14;444(7121):860-7. doi: 10.1038/nature05485.
Zotero 插件